Celltrion Inc - Asset Resilience Ratio

Latest as of March 2026: 0.56%

Celltrion Inc (068270) has an Asset Resilience Ratio of 0.56% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Celltrion Inc to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩129.99 Billion

≈ $88.09 Million USD Cash + Short-term Investments

Total Assets

₩23.16 Trillion

≈ $15.69 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2007–2025)

This chart shows how Celltrion Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Celltrion Inc (068270) total assets.

Liquid Assets Composition Over Time

This chart breaks down Celltrion Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 068270 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩129.99 Billion	0.56%
Total Liquid Assets	₩129.99 Billion	0.56%

Asset Resilience Insights

Limited Liquidity: Celltrion Inc maintains only 0.56% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Celltrion Inc Industry Peers by Asset Resilience Ratio

Compare Celltrion Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	72.23%
Abivax SA PA:ABVX	Biotechnology	2.34%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Celltrion Inc (2007–2025)

The table below shows the annual Asset Resilience Ratio data for Celltrion Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.54%	₩119.90 Billion ≈ $81.25 Million	₩22.33 Trillion ≈ $15.14 Billion	-0.16pp
2024-12-31	0.70%	₩146.61 Billion ≈ $99.36 Million	₩21.06 Trillion ≈ $14.27 Billion	-0.27pp
2023-12-31	0.97%	₩192.89 Billion ≈ $130.72 Million	₩19.92 Trillion ≈ $13.50 Billion	+0.23pp
2022-12-31	0.73%	₩43.28 Billion ≈ $29.33 Million	₩5.89 Trillion ≈ $3.99 Billion	+0.18pp
2021-12-31	0.56%	₩31.57 Billion ≈ $21.40 Million	₩5.67 Trillion ≈ $3.85 Billion	+0.28pp
2020-12-31	0.28%	₩14.03 Billion ≈ $9.51 Million	₩5.02 Trillion ≈ $3.40 Billion	-1.84pp
2019-12-31	2.12%	₩81.68 Billion ≈ $55.35 Million	₩3.86 Trillion ≈ $2.62 Billion	-1.36pp
2018-12-31	3.47%	₩121.64 Billion ≈ $82.43 Million	₩3.50 Trillion ≈ $2.37 Billion	-0.74pp
2017-12-31	4.21%	₩138.72 Billion ≈ $94.01 Million	₩3.29 Trillion ≈ $2.23 Billion	+4.02pp
2016-12-31	0.19%	₩5.77 Billion ≈ $3.91 Million	₩3.02 Trillion ≈ $2.05 Billion	-0.03pp
2015-12-31	0.22%	₩6.00 Billion ≈ $4.07 Million	₩2.75 Trillion ≈ $1.86 Billion	-1.08pp
2014-12-31	1.30%	₩30.15 Billion ≈ $20.43 Million	₩2.32 Trillion ≈ $1.57 Billion	-0.34pp
2013-12-31	1.64%	₩32.38 Billion ≈ $21.94 Million	₩1.98 Trillion ≈ $1.34 Billion	-1.25pp
2012-12-31	2.89%	₩50.01 Billion ≈ $33.89 Million	₩1.73 Trillion ≈ $1.17 Billion	+2.22pp
2011-12-31	0.66%	₩9.36 Billion ≈ $6.34 Million	₩1.41 Trillion ≈ $953.72 Million	-7.45pp
2010-12-31	8.12%	₩93.81 Billion ≈ $63.58 Million	₩1.16 Trillion ≈ $783.04 Million	+7.07pp
2009-12-31	1.05%	₩5.88 Billion ≈ $3.98 Million	₩559.20 Billion ≈ $378.96 Million	+0.27pp
2008-12-31	0.78%	₩3.89 Billion ≈ $2.64 Million	₩499.26 Billion ≈ $338.34 Million	-3.48pp
2007-12-31	4.25%	₩2.62 Billion ≈ $1.77 Million	₩61.46 Billion ≈ $41.65 Million	--

pp = percentage points

About Celltrion Inc

KO:068270 Korea Biotechnology

Market Cap

$28.95 Billion

₩42.72 Trillion KRW

Market Cap Rank

#931 Global

#17 in Korea

Share Price

₩186300.00

Change (1 day)

-0.96%

52-Week Range

₩159400.00 - ₩248500.00

All Time High

₩389079.95